These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21311849)

  • 1. Formation of mechanistic categories and local models to facilitate the prediction of toxicity.
    Cronin MT; Enoch SJ; Hewitt M; Madden JC
    ALTEX; 2011; 28(1):45-9. PubMed ID: 21311849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using toxicological evidence from QSAR models in practice.
    Benfenati E; Pardoe S; Martin T; Gonella Diaza R; Lombardo A; Manganaro A; Gissi A
    ALTEX; 2013; 30(1):19-40. PubMed ID: 23338804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes.
    Gissi A; Gadaleta D; Floris M; Olla S; Carotti A; Novellino E; Benfenati E; Nicolotti O
    ALTEX; 2014; 31(1):23-36. PubMed ID: 24247988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():1-6. PubMed ID: 19025328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling acute oral mammalian toxicity. 1. Definition of a quantifiable baseline effect.
    Koleva YK; Cronin MT; Madden JC; Schwöbel JA
    Toxicol In Vitro; 2011 Oct; 25(7):1281-93. PubMed ID: 21557997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integration of QSAR models for bioconcentration suitable for REACH.
    Gissi A; Nicolotti O; Carotti A; Gadaleta D; Lombardo A; Benfenati E
    Sci Total Environ; 2013 Jul; 456-457():325-32. PubMed ID: 23624006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-tier QSAR modeling strategy for estimating eye irritation potential of diverse chemicals in rabbit for regulatory purposes.
    Basant N; Gupta S; Singh KP
    Regul Toxicol Pharmacol; 2016 Jun; 77():282-91. PubMed ID: 27018829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro tests within the REACH information strategies.
    Louekari K; Sihvonen K; Kuittinen M; Sømnes V
    Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel technologies and an overall strategy to allow hazard assessment and risk prediction of chemicals, cosmetics, and drugs with animal-free methods.
    Leist M; Lidbury BA; Yang C; Hayden PJ; Kelm JM; Ringeissen S; Detroyer A; Meunier JR; Rathman JF; Jackson GR; Stolper G; Hasiwa N
    ALTEX; 2012; 29(4):373-88. PubMed ID: 23138508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring QSTR analysis of the toxicity of phenols and thiophenols using machine learning methods.
    Asadollahi-Baboli M
    Environ Toxicol Pharmacol; 2012 Nov; 34(3):826-31. PubMed ID: 23068157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.
    Stuard SB; Heinonen T
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to the EU REACH legislation.
    Grindon C; Combes R
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():5-10. PubMed ID: 16555955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-Based Toxicology Collaboration (EBTC). Editorial.
    von Aulock S
    ALTEX; 2013; 30(1):1. PubMed ID: 23451363
    [No Abstract]   [Full Text] [Related]  

  • 15. On the use of in silico tools for prioritising toxicity testing of the low-volume industrial chemicals in REACH.
    Rybacka A; Rudén C; Andersson PL
    Basic Clin Pharmacol Toxicol; 2014 Jul; 115(1):77-87. PubMed ID: 24428755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated testing strategies for use with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():7-27. PubMed ID: 19025329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular fingerprint-derived similarity measures for toxicological read-across: Recommendations for optimal use.
    Mellor CL; Marchese Robinson RL; Benigni R; Ebbrell D; Enoch SJ; Firman JW; Madden JC; Pawar G; Yang C; Cronin MTD
    Regul Toxicol Pharmacol; 2019 Feb; 101():121-134. PubMed ID: 30468762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel strategies for toxicological risk assessments.
    Roy A; Akbarsha MA
    ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of integrated testing strategies for REACH: motivation, background and introduction. Preface.
    Cronin MT; Garrod JF; Balls M
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():i-iii. PubMed ID: 19130698
    [No Abstract]   [Full Text] [Related]  

  • 20. Current and Future Perspectives on the Development, Evaluation, and Application of in Silico Approaches for Predicting Toxicity.
    Patlewicz G; Fitzpatrick JM
    Chem Res Toxicol; 2016 Apr; 29(4):438-51. PubMed ID: 26686752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.